• Share
  • Email
  • Print

Owen E. Waft

Partner
+971.4.427.2714
Fax +971.4.447.5225
Owen Waft is resident in the United Arab Emirates and is a senior corporate partner in K&L Gates’ Dubai office. Owen has particular experience in international cross border M&A, corporate finance, private equity, joint ventures and commercial matters across a broad range of sectors including financial services, telecommunications, technology, natural resources and life sciences.

Professional Background

Owen qualified as a lawyer in 1993. He joined the firm in 1994 and was made partner in 1997.

  • UAE joint venture for U.S. provider of services to marine industry.
  • Multi-jurisdiction private fundraising by UAE sports industry fund.
  • Investment in Qatari financial services company by U.K. household name business.
  • Multi-jurisdiction sale by auction of truck body manufacturer of industrial vehicles group.
  • Establishing Gulf Region presence for U.K. household name financial services company.
  • Saudi Arabian joint venture for German plastics industry company
  • Establishing fund for investment in international infrastructure equipment.
  • Fundraising and joint venture for Gulf Region television production company.
  • Gulf Region fundraising U.K. electronic payments company.
  • Establishing Gulf Region presence for leading U.K. funds industry business.
  • Joint venture with Canadian supplier for UAE based food industry company.
  • Acquisition of U.K./Cayman incorporated natural resources company for Japanese listed manufacturing company.
  • Sale of U.K. vehicle salvage service provider to U.S. market leader.
  • Pan-jurisdictional acquisition of printing technologies group.
  • Simultaneous acquisition of three industrial manufacturing businesses for German group.
  • Auction sale of Swedish pharmaceuticals group for U.S./U.K. pharmaceuticals company.
  • Advising fund for investment in Mexico energy related projects.
  • Sale of biotechnology company to Danish life sciences group.
  • Acquisition of pharmaceuticals company for NASDAQ listed specialty pharmaceuticals client.
  • Sale of Philippines agricultural business to U.K. company.
  • Cross border $70m investment in international pharmaceutical company by consortium of U.S. and U.K. based funds.
  • Investment in U.K. computer gaming technology company by Norwegian fund.